GC Biotherapeutics

GC Biotherapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 1
  • Investments
  • 1

GC Biotherapeutics General Information

Description

Operator of a biopharmaceutical company. The company manufactures and distributes intravenous immunoglobulin (IVIG) and albumin products that are used for the treatment of patients with infectious and immune diseases, and albumin, used as a blood-volumizing agent and in the treatment of burns.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Primary Office
  • 2911 Marie-Curie Avenue
  • Montreal, Quebec H4S 2C3
  • Canada
+1 (514) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GC Biotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GC Biotherapeutics‘s full profile, request access.

Request a free trial

GC Biotherapeutics Executive Team (2)

Name Title Board Seat Contact Info
Jae Bae Chief Executive Officer

1 Former Executive

GC Biotherapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GC Biotherapeutics‘s full profile, request access.

Request a free trial

GC Biotherapeutics Investments (1)

To view GC Biotherapeutics‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00. 07-Feb-2020 0000000000 000.00 Holding Companies